Abstract
The origin of the microheterogeneity of a highly purified antiinflammatory humanized monoclonal antibody prepared in mammalian cell culture has been investigated. This antibody is an IgG directed toward human CD 18 (a subunit of leukocyte integrins). When the IgG preparation is subjected to isoelectric focusing, it is found to contain four major species with pI values ranging from 6 to 7. Although the relative amounts of each form differ and some species are present only in small quantities, each has been isolated by a combination of high-resolution anion-exchange chromatography and isoelectric focusing. Comparative studies reveal no detectable differences in overall secondary (far UV circular dichroism) or tertiary (intrinsic fluorescence) structure, molecular weight (laser-desorption mass spectroscopy), or antigen binding activity. When each of the isolated species is incubated under conditions which favor deamidation, it is converted to forms of lower pI which appear to correspond to naturally observed species. While the isolated light chain is relatively homogeneous, the heavy chain exhibits a pattern of isoelectric focusing bands similar to that of the intact immunoglobulin. These results suggest that in this case, charge microheterogeneity is due to the sequential deamidation of the immunoglobulin heavy chain.
Similar content being viewed by others
REFERENCES
J. T. DiPiro, R. G. Hamilton, and J. P. Wei. Novel antibody drug products. Am. J. Surg. 164:77–84 (1992).
G. L. Boulianne, N. Hozumi, and M. J. Shulman. Production of functional chimeric mouse/human antibody. Nature 312:643–646 (1984).
L. Riechmann, M. Clark, H. Waldmann, and G. Winter. Reshaping human antibodies for therapy. Nature 332:323–327 (1988).
I. I. Singer, D. W. Kawka, J. A. DeMartino, B. L. Daugherty, K. O. Elliston, K. Alves, P. M. Cameron, G. C. Cuca, P. Davies, M. J. Forrest, D. M. Kazazis, M.-F. Law, A. B. Lenny, D. E. MacIntyre, R. Meurer, E. A. Padlan, S. Pandya, J. A. Schmidt, T. C. Seamans, S. Scott, M. Silberklang, A. R. Williamson, and G. E. Mark. Optimal humanization of 1B4, an anti-CD18 murine monoclonal antibody, is achieved by correct choice of human V-region framework sequences. J. Immuno. 150:2844–2857 (1993).
Z. L. Awdeh, A. R. Williamson, and B. A. Askonas. One cell-one immunoglobulin. Origin of limited heterogeneity of myeloma proteins. Biochem. J. 116:241–248 (1970).
E. Wenisch, S. Reiter, S. Hinger, F. Steindl, C. Tauer, A. Jungbauer, H. Katinger, and P. G. Righetti. Shifts of isoelectric points between cellular and secreted antibodies as revealed by isoelectric focusing and immobilized pH gradients. Electrophoresis 11:966–969 (1990).
R. D'Amelio, R. Biselli, R. Nisini, P. M. Matricardi, A. Aiuti, I. Mezzaroma, E. Pinter, O. Pontesilli, and F. Aiuti. Spectrotype of anti-gp120 antibodies remains stable during the course of HIV disease. J. AIDS 5:930–935 (1992).
R. G. Hamilton, C. B. Reimer, and L. S. Rodkey. Quality control of murine monoclonal antibodies using isoelectric focusing affinity immunoblot analysis. Hybridoma 6:205–217 (1987).
A. R. Williamson, M. R. Salaman, and H. W. Kreth. Microheterogeneity and allomorphism of proteins. Ann. N.Y. Acad. Sci. 209:210–224 (1973).
D. R. Hoffman. Studies on the structure and synthesis of immunoglobulins by isoelectric focusing. In N. J. Catsimpoolas and Drysdale (eds.), Biological and Biochemical Applications of Isoelectric Focusing, Plenum Press, New York and London, 1977, pp. 121–153.
B. J. Compton, J. S. Gerald, D. A. Lowe, and R. P. Elander. Micro isoelectric point heterogeneity of a murine monoclonal antibody (L6) originating from cell cultivation conditions. Biotech. Tech. 3:349–354 (1989).
M. F. Goldfarb. Two-dimensional electrophoretic analysis of immunoglobulin patterns in monoclonal gammopathies. Electrophoresis 13:440–444 (1992).
H. T. Wright. Nonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins. Crit. Rev. Biochem. Mol. Biol. 26:1–52 (1991).
S. Clarke, R. C. Stephenson, and J. D. Lowenson. Lability of asparagine and aspartic acid residues in proteins and peptides: Spontaneous deamidation and isomerization reactions. In T. J. Ahern and M. C. Manning (eds.), Stability of Protein Pharmaceuticals: Chemical and Physical Pathways of Protein Degration, Part A, Plenum Press, New York and London, 1992, pp. 1–29.
B. A. Johnson, J. M. Shirokawa, W. S. Hancock, M. W. Spellman, L. J. Basa, and D. W. Aswad. Formation of isoasparate at two distinct sites during in vitro aging of human growth hormone. J. Biol. Chem. 264:14262–14272. (1989).
J. A. DeMartino, B. L. Daugherty, M. F. Law, G. C. Cuca, K. Alves, M. Silberklang, and G. E. Mark. Rapid humanization and expression of murine monoclonal antibodies. Antibody Immunoconj. Radiopharm. 4:829–835 (1991).
M. F. Law, G. E. Mark, J. A. Schmidt, and I. I. Singer. Recombinant human anti-CD18 antibodies. Europe Patent Office Application 0-440-351-A2 (1991).
X. Saez-Llorens, H. S. Jafari, C. Severien, F. Parras, K. D. Olsen, E. J. Hansen, I. I. Singer, and G. H. McCracken. Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental haemophilus meningitis. J. Clin. Invest. 88:2003–2011 (1991).
Isoelectric Focusing: Principles and Methods, Technical Booklet Series, Pharmacia Fine Chemicals, Uppsala, Sweden; 1982, p. 97.
C. Sundstrom and K. Nilsson. Establishment and characterization of a human histiocytic lymphoma cell line (U 937). Int J. Cancer 17:565–577 (1976).
C. C. Yu Ip, W. J. Miller, D. J. Kubek, A.-M. Strang, H. van Halbeek, S. J. Piesecki, and J. A. Alhadeff. Structural characterization of the N-glycans of a recombinant hepatitis B surface antigen derived from yeast. Biochemistry 31:285–295 (1992).
R. J. Rothman, L. Warren, J. F. G. Vliegenthart, and K. J. Härd. Clonal analysis of the glycosylation of immunoglobulin G secreted by murine hybridomas. Biochemistry 28:1377–1384 (1989).
A. Kobata. Function and pathology of the sugar chains of human immunoglobulin G. Glycobiology 1:5–8 (1990).
E. Kun and E. B. Kearney. Ammonia. Methods Enzym. Anal. (2nd ed.) 4:1802–1806 (1974).
S. E. Zale and A. M. Klibanov. Why does ribonuclease irreversibly inactivate at high temperatures? Biochemistry 25:5432–5444 (1986).
C. R. Middaugh and G. W. Litman. Atypical glycosylation of an IgG monoclonal cryoimmunoglobulin. J. Biol. Chem. 262:3671–3673 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tsai, P.K., Bruner, M.W., Irwin, J.I. et al. Origin of the Isoelectric Heterogeneity of Monoclonal Immunoglobulin h1B4. Pharm Res 10, 1580–1586 (1993). https://doi.org/10.1023/A:1018912417607
Issue Date:
DOI: https://doi.org/10.1023/A:1018912417607